Skip to main content

Trulieve Cannabis Corp

For the period ended Sep 30, 2024. Filed Nov 5, 2024.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Sep 30, 2024 · Filed Nov 5, 2024

TRLV$11.09+0.7%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Condensed Consolidated Statements of Cash Flows

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)

(in thousands)

Nine Months EndedSeptember 30,
20242023
Cash flows from operating activities
Net loss$(99,015)$(498,346)
Adjustments to reconcile net loss to net cash provided by operating activities:
Depreciation and amortization84,16383,618
Depreciation included in cost of goods sold40,09845,397
Gain on debt extinguishment—(8,161)
Impairment and disposal of long-lived assets, net of (recoveries)(4,423)5,480
Impairment of goodwill—307,590
Amortization of operating lease right of use assets8,3397,794
Share-based compensation15,5797,415
Allowance for credit losses4,910866
Deferred income taxes(2,676)(18,696)
Loss from disposal of discontinued operations—69,840
Other non-cash changes8985,031
Changes in operating assets and liabilities:
Inventories(8,281)66,527
Accounts receivable(712)(1,856)
Prepaid expenses and other current assets(856)9,286
Other assets(6,101)2,047
Accounts payable and accrued liabilities4,6324,519
Income tax receivable / payable(4,337)(49,869)
Other liabilities202(14,392)
Operating lease liabilities(5,959)(6,933)
Deferred revenue5,327(6,005)
Uncertain tax position liabilities203,78061,837
Other long-term liabilities(662)(2,612)
Proceeds received from insurance for operating expenses5,903—
Net cash provided by operating activities240,80970,377
Cash flows from investing activities
Purchases of property and equipment(79,036)(30,998)
Capitalized interest(866)114
Purchases of internal use software(18,287)(7,741)
Purchases of short-term investments(80,000)—
Cash paid for licenses(7,000)(3,971)
Payment for initial direct costs on finance leases(647)—
Proceeds from disposal activities1,00311,723
Proceeds from notes receivable repayments872565
Proceeds received from insurance recoveries on property and equipment527—
Net cash used in investing activities(183,434)(30,308)
Cash flows from financing activities
Payments for taxes related to net share settlement of equity awards(12,258)—
Payments on finance lease obligations(5,513)(5,720)
Payments on notes payable(3,839)(5,521)
Payments on construction finance liabilities(2,524)(1,285)
Payments and costs related to consolidated VIE settlement transaction(5,077)—
Distributions to subsidiary non-controlling interest(1,081)(50)
Payments on private placement notes—(47,595)
Payments for debt issuance costs—(428)
Proceeds from non-controlling interest holders' subscription3,000—
Proceeds from equity exercises210—
Net cash used in financing activities(27,082)(60,599)
Net increase (decrease) in cash and cash equivalents30,293(20,530)
Cash, cash equivalents, and restricted cash, beginning of period207,979213,792
Cash and cash equivalents of discontinued operations, beginning of period3015,702
Less: cash and cash equivalents of discontinued operations, end of period—(94)
Cash, cash equivalents, and restricted cash, end of period$238,573$198,870
Supplemental disclosure of cash flow information
Cash paid during the period for
Interest$41,608$52,036
Income taxes paid, net of (refunds)(46,748)113,187
Noncash investing and financing activities
ASC 842 lease additions - operating and finance leases$42,881$12,019
Purchases of property and equipment in accounts payable and accrued liabilities10,4624,284
Reclassification of assets to held for sale7,04418,396
Adjustment of redeemable non-controlling interest to maximum redemption value9,010—
Noncash partial extinguishment of construction finance liability—18,486

The condensed consolidated statements of cash flows include continuing operations and discontinued operations for the periods presented.

September 30,
20242023
Beginning of period:
Cash and cash equivalents (1)$201,372$207,185
Restricted cash6,6076,607
Cash, cash equivalents and restricted cash$207,979$213,792
End of period:
Cash and cash equivalents (2)$237,666$192,159
Restricted cash9076,711
Cash, cash equivalents and restricted cash$238,573$198,870

(1)Excludes cash associated with discontinued operations totaling$0.3 million and $5.7 million as of December 31, 2023 and 2022, respectively.

(2)Excludes cash associated with discontinued operations totaling zero and $0.1 million as of September 30, 2024 and 2023, respectively.

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.